Together, the published studies and dataset analysis suggest that ALDH1A3 expression dysregulation in cancer is multifactorial and mediation by genetic, epigenetic, post-transcriptional, and post-translational mechanisms. This evidence concerns the gene ALDH1A3 and cancer.